Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
China · Delayed Price · Currency is CNY 7.18
-0.11 (-1.51%)
Apr 17, 2026, 3:00 PM CST
SHA:600222 Revenue
In the year 2025, Henan Taloph Pharmaceutical Stock Co.,Ltd had annual revenue of 1.76B CNY, down -9.46%. Henan Taloph Pharmaceutical Stock Co.,Ltd had revenue of 570.89M in the quarter ending December 31, 2025, a decrease of -4.97%.
Revenue
1.76B
Revenue Growth
-9.46%
P/S Ratio
2.26
Revenue / Employee
793.94K
Employees
2,214
Market Cap
3.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.76B | -183.63M | -9.46% |
| Dec 31, 2024 | 1.94B | -128.49M | -6.21% |
| Dec 31, 2023 | 2.07B | 109.21M | 5.57% |
| Dec 31, 2022 | 1.96B | 356.18M | 22.20% |
| Dec 31, 2021 | 1.60B | 187.42M | 13.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinhe Biotechnology CO., LTD. | 2.75B |
| PKU HealthCare Corp.,Ltd. | 1.76B |
| Huaren Pharmaceutical | 1.26B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| LanZhou Foci Pharmaceutical | 915.53M |
| Zhejiang Cheng Yi Pharmaceutical | 790.86M |
| Qianjiang Yongan Pharmaceutical | 783.17M |
| Tibet AIM Pharm. | 628.02M |